Literature DB >> 18424700

Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model.

Bryce Chackerian1, Marisa R Durfee, John T Schiller.   

Abstract

The ability to distinguish between self and foreign Ags is a central feature of immune recognition. For B cells, however, immune tolerance is not absolute, and factors that include Ag valency, the availability of T help, and polyclonal B cell stimuli can influence the induction of autoantibody responses. Here, we evaluated whether multivalent virus-like particle (VLP)-based immunogens could induce autoantibody responses in well-characterized transgenic (Tg) mice that express a soluble form of hen egg lysozyme (HEL) and in which B cell tolerance to HEL is maintained by anergy. Immunization with multivalent VLP-arrayed HEL, but not a trivalent form of HEL, induced high-titer Ab responses against HEL in both soluble HEL Tg mice and double Tg mice that also express a monoclonal HEL-specific BCR. Induction of autoantibodies against HEL was not dependent on coadministration of strong adjuvants, such as CFA. In contrast to previous data showing the T-independent induction of Abs to foreign epitopes on VLPs, the ability of HEL-conjugated VLPs to induce anti-HEL Abs in tolerant mice was dependent on the presence of CD4(+) Th cells, and could be enhanced by the presence of pre-existing cognate T cells. In in vitro studies, VLP-conjugated HEL was more potent than trivalent HEL in up-regulating surface activation markers on purified anergic B cells. Moreover, immunization with VLP-HEL reversed B cell anergy in vivo in an adoptive transfer model. Thus, Ag multivalency and T help cooperate to reverse B cell anergy, a major mechanism of B cell tolerance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424700      PMCID: PMC3493123          DOI: 10.4049/jimmunol.180.9.5816

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

Review 1.  Transgenic mice and analysis of B-cell tolerance.

Authors:  C C Goodnow
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

2.  Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor.

Authors:  K Wheeler; J D Pound; J Gordon; R Jefferis
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

3.  Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions.

Authors:  J M Eris; A Basten; R Brink; K Doherty; M R Kehry; P D Hodgkin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

4.  Studies on the immunogenicity and tolerogenicity of T-independent antigens.

Authors:  R Z Dintzis; M H Middleton; H M Dintzis
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

5.  Molecular determinants of immunogenicity: the immunon model of immune response.

Authors:  H M Dintzis; R Z Dintzis; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

6.  The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence.

Authors:  R Z Dintzis; M Okajima; M H Middleton; G Greene; H M Dintzis
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

7.  Induction of self-tolerance in mature peripheral B lymphocytes.

Authors:  C C Goodnow; J Crosbie; H Jorgensen; R A Brink; A Basten
Journal:  Nature       Date:  1989-11-23       Impact factor: 49.962

8.  Mechanisms of anti-CD4-mediated depletion and immunotherapy. A study using a set of chimeric anti-CD4 antibodies.

Authors:  S E Alters; K Sakai; L Steinman; V T Oi
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

9.  Reduced life span of anergic self-reactive B cells in a double-transgenic model.

Authors:  D A Fulcher; A Basten
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

10.  Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells.

Authors:  M P Cooke; A W Heath; K M Shokat; Y Zeng; F D Finkelman; P S Linsley; M Howard; C C Goodnow
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  43 in total

1.  Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7.

Authors:  Jerri do Carmo Caldeira; Alexander Medford; Rhonda C Kines; Christopher A Lino; John T Schiller; Bryce Chackerian; David S Peabody
Journal:  Vaccine       Date:  2010-04-29       Impact factor: 3.641

Review 2.  Therapeutic antibodies directed at G protein-coupled receptors.

Authors:  Catherine J Hutchings; Markus Koglin; Fiona H Marshall
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

3.  Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).

Authors:  Rachael Watson; Emma Wearmouth; Amy-Claire McLoughlin; Arthur Jackson; Sophie Ward; Paula Bertram; Karim Bennaceur; Catriona E Barker; Isabel Y Pappworth; David Kavanagh; Susan M Lea; John P Atkinson; Timothy H J Goodship; Kevin J Marchbank
Journal:  Mol Immunol       Date:  2014-08-21       Impact factor: 4.407

Review 4.  Vaccines Targeting PCSK9: A Promising Alternative to Passive Immunization with Monoclonal Antibodies in the Management of Hyperlipidaemia?

Authors:  Stefan Weisshaar; Markus Zeitlinger
Journal:  Drugs       Date:  2018-06       Impact factor: 9.546

5.  Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine.

Authors:  Zoe Hunter; Hugh D Smyth; Paul Durfee; Bryce Chackerian
Journal:  Vaccine       Date:  2009-10-20       Impact factor: 3.641

Review 6.  Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform.

Authors:  John P O'Rourke; David S Peabody; Bryce Chackerian
Journal:  Curr Opin Virol       Date:  2015-03-29       Impact factor: 7.090

Review 7.  Beyond antigens and adjuvants: formulating future vaccines.

Authors:  Tyson J Moyer; Andrew C Zmolek; Darrell J Irvine
Journal:  J Clin Invest       Date:  2016-03-01       Impact factor: 14.808

Review 8.  Structure-Based Vaccine Antigen Design.

Authors:  Barney S Graham; Morgan S A Gilman; Jason S McLellan
Journal:  Annu Rev Med       Date:  2019-01-27       Impact factor: 13.739

9.  Autologous albumin enhances the humoral immune response to capsular polysaccharide covalently coattached to bacteria-sized latex beads.

Authors:  Jesus Colino; Leah Duke; Clifford M Snapper
Journal:  Eur J Immunol       Date:  2014-02-27       Impact factor: 5.532

Review 10.  Immunological tolerance as a barrier to protective HIV humoral immunity.

Authors:  Kristin Ms Schroeder; Amanda Agazio; Raul M Torres
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.